Curis Announces Pricing of Public Offering of Common Stock

Curis (NASDAQ:CRIS) announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock.
As quoted in the press release:

Curis intends to use the net proceeds from the Offering, together with its existing cash and investments, to continue development of CUDC-907, as well as CA-170, CA-327 and CA-4948 in collaboration with Aurigene Discovery Technologies Limited (“Aurigene”), and any additional product candidates for which it exercises its option to exclusively in-license from Aurigene, to fund potential acquisitions of new business, technologies or products that it believes will complement or expand its business, and for general working capital and capital expenditures.

Click here to read the full press release.

Source: globenewswire.com